Literature DB >> 19223179

Pleurotus species convert monoterpenes to furanoterpenoids through 1,4-endoperoxides.

Sven Krügener1, Carmen Schaper, Ulrich Krings, Ralf G Berger.   

Abstract

Enzymatic synthesis of furanoterpenoids from beta-myrcene and related monoterpenes was observed using a solubilised enzyme fraction of mycelium lyophilisates of several Pleurotus species. The initial enzymatic step, the incorporation of molecular oxygen into the conjugated 1,3-diene moiety, was similar to a 2+4 cycloaddition of 1,3-dienes with dienophilic (1)O(2), and was followed by a non-catalysed degradation sequence leading to the furans. The cyclic peroxides 3,6-dihydro-4-(2-(3,3-dimethyloxiran-2-yl)ethyl)-1,2-dioxine and 5-(3,6-dihydro-1,2-dioxin-4-yl)-2-methylpentan-2-ol were identified as key intermediates. Biotransformation of beta-myrcene in (18)O-labelled HEPES-buffer did not yield a detectable label in perillene, so a water addition to 3,10-epoxy-beta-myrcenes as an alternative was ruled out. The pathway suggested presents a substantiated biogenetic scheme for the formation of monoterpenoid furans and opens biotechnological access to valuable natural flavour compounds, such as perillene and rosefurane. Only one metabolite, identified as the new natural compound 6-methyl-2-methylene-hept-5-enal, carried the (18)O-label. The enzymatic formation of this compound through a 1,2-endoperoxide (3-(5-methyl-1-methylene-hex-4-enyl)-[1,2]-dioxetane) is suggested. The label may simply result from a chemical oxygen exchange between the carbonyl group and the (18)O-labelled water.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223179     DOI: 10.1016/j.biortech.2009.01.001

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  1 in total

1.  A three-enzyme-system to degrade curcumin to natural vanillin.

Authors:  Vida Esparan; Ulrich Krings; Marlene Struch; Ralf G Berger
Journal:  Molecules       Date:  2015-04-14       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.